☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Velsipity
Insights+: EMA Marketing Authorization of New Drugs in February 2024
March 20, 2024
Pfizer’s Velsipity (etrasimod) Receives the European Commission’s Approval for the Treatment of Severely Active Ulcerative Colitis
February 20, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.